MED Medifast, Inc.

NYSE
$11.44

Medifast, Inc. (MED) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is a loss of $0.60 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.9% since its last earnings release on August 3, 2026.

Medifast Beat Consensus Estimates, Guides to a Smaller Loss
Monday, August 3, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.60)
Rev est $62.45M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.48

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Medifast, Inc.

Medifast Inc is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins.

Sector

Staples

Industry

Processed / Packaged Goods

Held By 1 ETFs, by dollar flow